Latest Financials News

Pharmx Technologies reported a 13% increase in FY25 revenues to $7.53 million, driven by strong growth across its Gateway and Marketplace platforms. The company maintained positive EBITDA and a solid cash position despite legal expenses, setting the stage for an ambitious FY26 growth strategy.

Vicinity Centres reported a robust FY25 with statutory net profit surpassing $1 billion and Funds From Operations reaching the top end of guidance, underpinned by strategic asset acquisitions and strong portfolio performance.

Pharmx Technologies has reported a 13% revenue increase to $7.5 million for FY25, driven by expanded partnerships and platform innovations, despite a dip in EBITDA due to heavy investment.

The Lottery Corporation Limited has announced a fully franked ordinary dividend of AUD 0.085 per share for the first half of FY2025, accompanied by a Dividend Reinvestment Plan available to Australian and New Zealand shareholders.

Papyrus Australia has signed a binding term sheet with TBS Mining Solutions to produce a biodegradable version of the Collar Keeper® product, marking a significant step in commercialising sustainable mining solutions.

Lycopodium Limited delivered FY25 results at the top end of guidance, reporting strong revenue and profit growth alongside strategic moves to deepen its global footprint, notably through the acquisition of Argentinian engineering firm SAXUM.

Pharmx Technologies Limited reported a 13% increase in revenue for FY25, driven by expanded supplier-pharmacy connections and Marketplace platform growth, while profit before tax declined due to significant investments in new technology platforms.

Vicinity Centres has announced an ordinary unfranked dividend of AUD 0.0605 per security for the six months ending June 2025, accompanied by a Dividend Reinvestment Plan offering a 1% discount.

Superloop has reported a robust FY25 with a 31% revenue increase and significant market share gains in the nbn broadband sector, alongside a positive net profit after tax.

Opthea Limited has terminated its sozinibercept wet AMD program following Phase 3 trial failures and settled a major funding agreement, setting the stage for a strategic reset.

COSOL Limited reported a $7.9 million net profit for FY25 on record $116.8 million revenue, driven by strong organic growth and a strategic acquisition. The company signals margin expansion and robust earnings growth ahead, fueled by AI and digital transformation investments.

Superloop Limited has reported a landmark FY25, posting its first positive net profit after tax since its turnaround began, alongside robust revenue growth and a significant expansion in its customer base.